Scientific Literature Search

Source record

An update on the genetics of dementia with Lewy bodies.

Vergouw LJM, van Steenoven I, van de Berg WDJ, Teunissen CE, van Swieten JC, Bonifati V, Lemstra AW, de Jong FJ.

Parkinsonism Relat Disord · 2017-07-13

DOI: 10.1016/j.parkreldis.2017.07.009PMID: 28734699

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Nortriptyline inhibits aggregation and neurotoxicity of alpha-synuclein by enhancing reconfiguration of the monomeric form.

Collier TJ, Srivastava KR, Justman C, Grammatopoulous T, Hutter-Paier B, Prokesch M, Havas D, Rochet JC, Liu F, Jock K, de Oliveira P, Stirtz GL, Dettmer U, Sortwell CE, Feany MB, Lansbury P, Lapidus L, Paumier KL.

Neurobiol Dis · 2017-07-12

DOI: 10.1016/j.nbd.2017.07.007PMID: 28711409

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Open access

Genetic Variants in SNCA and the Risk of Sporadic Parkinson's Disease and Clinical Outcomes: A Review.

Campêlo CLDC, Silva RH.

Parkinsons Dis · 2017-07-11

DOI: 10.1155/2017/4318416PMID: 28781905

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Open access

A proteomic analysis of LRRK2 binding partners reveals interactions with multiple signaling components of the WNT/PCP pathway.

Salašová A, Yokota C, Potěšil D, Zdráhal Z, Bryja V, Arenas E.

Mol Neurodegener · 2017-07-11

DOI: 10.1186/s13024-017-0193-9PMID: 28697798

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Monomeric and fibrillar α-synuclein exert opposite effects on the catalytic cycle that promotes the proliferation of Aβ42 aggregates.

Chia S, Flagmeier P, Habchi J, Lattanzi V, Linse S, Dobson CM, Knowles TPJ, Vendruscolo M.

Proc Natl Acad Sci U S A · 2017-07-11

DOI: 10.1073/pnas.1700239114PMID: 28698377

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Open access

αSynuclein control of mitochondrial homeostasis in human-derived neurons is disrupted by mutations associated with Parkinson's disease.

Pozo Devoto VM, Dimopoulos N, Alloatti M, Pardi MB, Saez TM, Otero MG, Cromberg LE, Marín-Burgin A, Scassa ME, Stokin GB, Schinder AF, Sevlever G, Falzone TL.

Sci Rep · 2017-07-11

DOI: 10.1038/s41598-017-05334-9PMID: 28698628

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Open access

Study of Molecular Mechanisms of α-Synuclein Assembly: Insight into a Cross-β Structure in the N-Termini of New α-Synuclein Fibrils.

Bloch DN, Miller Y.

ACS Omega · 2017-07-10

DOI: 10.1021/acsomega.7b00459PMID: 30023693

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Open access

Role of Apolipoproteins and α-Synuclein in Parkinson's Disease.

Emamzadeh FN.

J Mol Neurosci · 2017-07-10

DOI: 10.1007/s12031-017-0942-9PMID: 28695482

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Computational investigation on the effects of H50Q and G51D mutations on the α-Synuclein aggregation propensity.

Sanjeev A, Mattaparthi VSK.

J Biomol Struct Dyn · 2017-07-10

DOI: 10.1080/07391102.2017.1347060PMID: 28650719

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Neuromelanin magnetic resonance imaging of the substantia nigra in LRRK2-related Parkinson's disease.

Correia Guedes L, Reimão S, Paulino P, Nunes RG, Bouça-Machado R, Abreu D, Gonçalves N, Soares T, Fabbri M, Godinho C, Pita Lobo P, Neutel D, Quadri M, Coelho M, Rosa MM, Campos J, Outeiro TF, Sampaio C, Bonifati V, Ferreira JJ.

Mov Disord · 2017-07-07

DOI: 10.1002/mds.27083PMID: 28686310

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Pathophysiological heterogeneity in Parkinson's disease: Neurophysiological insights from LRRK2 mutations.

Kojovic M, Kassavetis P, Pareés I, Georgiev D, Rocchi L, Balint B, Foltynie T, Rothwell J, Bhatia K.

Mov Disord · 2017-07-07

DOI: 10.1002/mds.27091PMID: 28686318

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Open access

Using KASP technique to screen LRRK2 G2019S mutation in a large Tunisian cohort.

Landoulsi Z, Benromdhan S, Ben Djebara M, Damak M, Dallali H, Kefi R, Abdelhak S, Gargouri-Berrechid A, Mhiri C, Gouider R.

BMC Med Genet · 2017-07-06

DOI: 10.1186/s12881-017-0432-5PMID: 28683740

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.

14.777 articles found

An update on the genetics of dementia with Lewy bodies.

Nortriptyline inhibits aggregation and neurotoxicity of alpha-synuclein by enhancing reconfiguration of the monomeric form.

Genetic Variants in SNCA and the Risk of Sporadic Parkinson's Disease and Clinical Outcomes: A Review.

A proteomic analysis of LRRK2 binding partners reveals interactions with multiple signaling components of the WNT/PCP pathway.

Monomeric and fibrillar α-synuclein exert opposite effects on the catalytic cycle that promotes the proliferation of Aβ42 aggregates.

αSynuclein control of mitochondrial homeostasis in human-derived neurons is disrupted by mutations associated with Parkinson's disease.

Study of Molecular Mechanisms of α-Synuclein Assembly: Insight into a Cross-β Structure in the N-Termini of New α-Synuclein Fibrils.

Role of Apolipoproteins and α-Synuclein in Parkinson's Disease.

Computational investigation on the effects of H50Q and G51D mutations on the α-Synuclein aggregation propensity.

Neuromelanin magnetic resonance imaging of the substantia nigra in LRRK2-related Parkinson's disease.

Pathophysiological heterogeneity in Parkinson's disease: Neurophysiological insights from LRRK2 mutations.

Using KASP technique to screen LRRK2 G2019S mutation in a large Tunisian cohort.

Filters